Since COVID-19 cases continued to register high levels in the first half of 2021, demand for analgesics has remained strong. Sales in the first half of 2020 soared (due to stockpiling) but this was followed by negative demand in the second half.
Analgesics remains saturated in 2021, led by multinational companies. Reckitt Benckiser Romania, which generated the most sales in 2019, is second to Zentiva, which is seeing success from its brands Antinevralgic P, Paracetamol Zentiva and Ibalgin, trading on the low prices and high quality of its products.
The distribution of analgesics in Romania is not well developed, with a range of specific regulations hampering growth. As a result, pharmacies will continue to be the main distribution channel in 2021.
Since life in Romania is expected to be less restricted by COVID-19 in 2022, demand for analgesics is also projected to stabilise as consumers will resume their pre-pandemic activities. Accordingly, the category is set to record stable and moderate growth rates throughout 2026.
Topical analgesics/anaesthetic products are expected to gain consumer confidence in the forecast period, especially as the population is ageing, leading to more people experiencing problems with articular pain. Topical analgesics/anaesthetic products are perceived as less harmful for the digestive system but also more affordable for lower-income consumers and pensioners.
Analgesics is a large and diverse product area in Romania and demand is expected to remain spread relatively evenly over numerous products, sustained by a high level of self-medication among consumers. Thus, positive growth over the forecast period is set to be based on steady growth across numerous products, including adult aspirin, acetaminophen, ibuprofen and topical analgesics/anaesthetic, which are likely to keep being supported by heavy advertising.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Romania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Romania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page